Cocrystal Pharma, Inc. — Director's Dealing 2021

Feb 12, 2021

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Cocrystal Pharma, Inc. (COCP)
CIK: 0001412486
Period of Report: 2020-12-31

Reporting Person: Lee Sam (President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-24	Stock Options (Right to Buy)	$1.30	A	50000	Acquired	2030-11-24	Common Stock (50000)	Direct

Footnotes

F1: The stock options were issued pursuant to the 2015 Equity Incentive Plan and are intended to be incentive stock options within the meaning of Section 422 of the Internal Revenue Code.

F2: The stock options vest as follows: 25,000 incentive stock options will vest on the one year anniversary of the grant date and the remaining 25,000 incentive stock options will vest in eight equal quarterly increments with the first such quarterly increment vesting on February 28, 2022, subject to continued employment on each applicable vesting date.